Xenon Pharmaceuticals Inc (XENE) — Analysis Summary
Xenon Pharmaceuticals Inc (XENE) has a market cap of $5.42B with year-over-year revenue growth of +0.0%. Net margin stands at -2483.9%. The stock trades at a P/E ratio of -23.1.
Key Takeaways
- Revenue changed +0.0% year-over-year
- Net margin of -2483.9%
- P/E ratio of -23.1
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, XENE posted revenue growth of +0.0% and trades at a P/E of -23.1.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.